Get the Stockscreener App
15.00
0.86%
-0.1279
Schrodinger Inc stock is traded at $15.00, with a volume of 521.28K.
It is down -0.86% in the last 24 hours and down -2.15% over the past month.
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.
See More
Previous Close:
$15.13
Open:
$15.32
24h Volume:
521.28K
Relative Volume:
0.39
Market Cap:
$1.12B
Revenue:
$254.91M
Net Income/Loss:
$-103.48M
P/E Ratio:
-10.69
EPS:
-1.4036
Net Cash Flow:
$-148.35M
1W Performance:
-2.09%
1M Performance:
-2.15%
6M Performance:
-8.65%
1Y Performance:
-33.30%
1-Day Range:
$14.61
$15.35
1-Week Range:
$14.61
$15.40
52-Week Range:
$10.95
$23.02
Schrodinger Inc Stock (SDGR) Company Profile
Name
Schrodinger Inc
Sector
Industry
Phone
503-299-1150
Address
1540 BROADWAY, NEW YORK, NY
Compare SDGR vs VEEV, BTSG, TEM, HQY, TXG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SDGR
Schrodinger Inc
|
15.02 | 1.13B | 254.91M | -103.48M | -148.35M | -1.4036 |
VEEV
Veeva Systems Inc
|
186.47 | 29.17B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
72.92 | 13.71B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
43.48 | 8.28B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
94.96 | 7.89B | 1.34B | 230.70M | 440.96M | 2.6695 |
TXG
10 X Genomics Inc
|
46.94 | 6.10B | 638.78M | -22.66M | 122.18M | -0.1744 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-15-25 | Upgrade | BofA Securities | Neutral → Buy |
| Sep-30-25 | Initiated | Goldman | Neutral |
| Aug-15-25 | Downgrade | Citigroup | Buy → Neutral |
| Aug-14-25 | Initiated | Barclays | Overweight |
| Jul-03-25 | Resumed | Morgan Stanley | Equal-Weight |
| Jul-02-24 | Initiated | Leerink Partners | Outperform |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Overweight |
| May-05-23 | Resumed | Piper Sandler | Overweight |
| Dec-19-22 | Initiated | Goldman | Neutral |
| Mar-01-22 | Initiated | Citigroup | Buy |
| Nov-19-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-19-21 | Initiated | Piper Sandler | Overweight |
| Nov-11-21 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-13-21 | Initiated | Berenberg | Buy |
| Sep-01-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-25-21 | Initiated | Craig Hallum | Buy |
| Nov-23-20 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-12-20 | Upgrade | Jefferies | Hold → Buy |
| Mar-02-20 | Initiated | BMO Capital Markets | Outperform |
| Mar-02-20 | Initiated | Jefferies | Hold |
| Mar-02-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Schrodinger Inc Stock (SDGR) Latest News
Schrödinger, Inc. (SDGR) stock price, news, quote and history - Yahoo Finance UK
Enterprise value to revenue forward of Schrodinger, Inc. – NASDAQ:SDGR - TradingView
An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the Numbers - marketscreener.com
Schrödinger, Inc. (SDGR) Stock Price, News, Quote & History - Yahoo! Finance Canada
Schrödinger to announce Q2 2026 results on August 5 - scanx.trade
Schrödinger to Announce Second Quarter 2026 Financial Results on August 5 - BioSpace
Enterprise value to revenue forward of Schrodinger, Inc. – FWB:43Z - TradingView
Schrodinger, Inc. $SDGR Shares Purchased by Amova Asset Management Americas Inc. - MarketBeat
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)July 20, 2026 - BioSpace
Schrodinger (SDGR) Grants Restricted Stock Units to New Employees - GuruFocus
Schrodinger grants new hires RSUs covering 3,691 shares under inducement plan - Bitget
Schrödinger (SDGR) Jefferies London Healthcare Conference 2025 Summary - Quartr
Schrödinger (SDGR) AGM 2026 Summary - Quartr
Schrödinger (SDGR) Jefferies London Healthcare Conference 2024 Summary - Quartr
Schrodinger CFO Rachit Jain sells $13,647 in stock - Investing.com UK
Schrodinger CFO Rachit Jain sells $13,647 in stock By Investing.com - Investing.com Nigeria
Form 4 Schrodinger Inc For: 17 July By Investing.com - Investing.com Nigeria
Schrodinger (SDGR) CFO sells 875 shares for RSU tax withholding - Stock Titan
Enterprise value to revenue forward of Schrodinger, Inc. – DUS:43Z - TradingView
Form 144 Schrodinger For: 16 July By Investing.com - Investing.com Canada
Hong Kong Stock Market Alert | Simcere Pharmaceutical (02096) Surges Over 6% Intraday Following Global Drug Discovery and Development Collaboration Agreement with U.S.-based Schrödinger, Inc. - 富途牛牛
Price to book forward of Schrodinger, Inc. – NASDAQ:SDGR - TradingView
Price to earnings forward of Schrodinger, Inc. – BOATS:SDGR - TradingView
BMO Capital Remains a Buy on Schrodinger (SDGR) - The Globe and Mail
Enterprise value to EBITDA forward of Schrodinger, Inc. – NASDAQ:SDGR - TradingView
Generative AI in Drug Discovery: Revolutionizing Pharmaceutical Research and Development - GlobeNewswire Inc.
Price to sales forward of Schrodinger, Inc. – NASDAQ:SDGR - TradingView
(SDGR) Volatility Zones as Tactical Triggers - Stock Traders Daily
Schrodinger Inc. (SDGR) Jumps 3.73% as Software-Driven Drug Discovery Gains TractionGap and Reverse - dars.gov.et
Schrödinger: Surviving, If Not Thriving, In The Tricky AI Drug Discovery Field (SDGR) - Seeking Alpha
Schrodinger explores computational chemistry. Nasdaq biotech stock leans on its platform - AD HOC NEWS
Citigroup Downgrades Schrödinger (SDGR) - MSN
SDGRSchrodinger Inc Latest SEC Filings - Finviz
Jain Rachit, Schrodinger CFO, sells $21k in SDGR stock By Investing.com - Investing.com Nigeria
SDGR Q1 2026 Earnings: Wider‑Than‑Expected Loss Reported; Shares Edge UpOperating Margin Analysis - dars.gov.et
Form 144 Schrodinger For: 1 July By Investing.com - Investing.com India
Enterprise value to EBIT forward of Schrodinger, Inc. – NASDAQ:SDGR - TradingView
A Look at Schrodinger Inc (SDGR) After 6.6% Decline -- GF Value $26.32 vs Price $16.25 - GuruFocus
Schrodinger, Inc. Receives $57 Million from Eli Lilly’s Acquisition of Ajax Therapeutics – Key Financial Update - Minichart
Form 4 Schrodinger Inc For: 29 June By Investing.com - Investing.com South Africa
Schrodinger receives ~$57M cash payment after Eli Lilly acquisition of Ajax - TradingView
Schrodinger Inc. (SDGR) Surges Over 3% as Stock Approaches Key Resistance LevelDividend Stock Picks - dars.gov.et
Strength Seen in Senseonics (SENS): Can Its 6.1% Jump Turn into More Strength? - Yahoo Finance
Price-Driven Insight from (SDGR) for Rule-Based Strategy - Stock Traders Daily
Schrodinger Inc (SDGR) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Schrodinger, Inc. Actuals & Estimates (SWB:43Z) - TradingView
Schrodinger, Inc. Actuals & Estimates (NASDAQ:SDGR) - TradingView
Schrodinger, Inc. Actuals & Estimates (DUS:43Z) - TradingView
SDGR Forecast — Price Target — Prediction for 2027 - TradingView
Schrodinger Inc Stock (SDGR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.83%
1.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):